Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Those Infected with HIV May Benefit From Infection with Another Virus, Says Jefferson Virologist

04.03.2004


Writing in the New England Journal of Medicine, Roger Pomerantz, M.D., suggests that understanding how HIV interacts with another virus, GBV-C, may help researchers devise improved therapies.



Another virus could hold a key to helping researchers devise new strategies against HIV, the virus that causes AIDS. A new study appearing March 4 in the New England Journal of Medicine shows that individuals infected with two viruses – HIV and the little known GBV-C – actually do better than those infected with only HIV.

According to Roger J. Pomerantz, M.D., professor of medicine, biochemistry and molecular pharmacology, director of the Division of Infectious Diseases and Environmental Medicine and director of the Center for Human Virology and Biodefense at Jefferson Medical College of Thomas Jefferson University in Philadelphia, the HIV-GBV-C connection may be the first known example of infection with two human viruses being better for a person than infection with only one – in this case, HIV.


“The [New England Journal] paper is very important because it sets to rest a controversial issue,” says Dr. Pomerantz, who co-wrote an accompanying editorial in the journal. The study analyzed results from the Multicenter Acquired Immunodeficiency Syndrome Cohort Study, which involved following a large group of HIV-infected men in the United States over 15 years. “People who are dual-infected do better than those infected with only HIV. They do better in terms of being less likely and taking a longer time to progress to AIDS, in addition to being less likely to die from AIDS.”

Understanding this viral relationship, he says, could have important implications.

“If we could understand the mechanism behind this phenomenon, maybe we could copy nature and develop a copycat molecule – and a better antiviral,” Dr. Pomerantz says.

Dr. Pomerantz should know. He was skeptical when he initially encountered several small, unconfirmed studies a few years ago showing that HIV-infected individuals appeared to do better when they also were infected with GBV-C. Viruses such as Epstein-Barr virus and herpes simplex 2, for example, are supposed to make things worse. And GBV-C, which is closely related to hepatitis viruses and which until recently was called hepatitis G virus, doesn’t cause any known disease.

In July, he and his co-workers at Jefferson and at the University of Catania in Sicily, reported results in the Annals of Internal Medicine of their study in which they compared a group of individuals in Sicily infected with both viruses (the combination of infections is more prevalent in Mediterranean countries) to those with only HIV. They too found the former group did surprisingly better. “It took longer for them to progress to AIDS, and fewer progressed,” he says, even when they “normalized the data for drugs” they took. Pomerantz offers some potential explanations for the findings of both studies.

In his group’s study, he says, the researchers found a difference in the T cells and the cytokines, the chemicals made to control the immune system. “Those who are dual-infected have a better, more protective cytokine profile, one that’s found in healthier people than that found in individuals just infected with HIV,” he explains.

Perhaps, he says, GBV-C somehow maintains the “good cytokine” profile, “enabling individuals to mount a stronger immune response to HIV, keeping them healthier and better able to keep the viral load lower.”

Another possibility, he notes, is that GBV-C could somehow interfere with HIV entry into cells. Some laboratory data show GBV-C may decrease the co-receptor that allows HIV into cells, in effect acting as a “viral antiviral.” GBV-C might also activate certain types of innate immunity, which involve known cellular factors that protect cells.

Steven Benowitz | TJUH
Further information:
http://www.jeffersonhospital.org/news/e3front.dll?durki=17561

More articles from Health and Medicine:

nachricht Research offers clues for improved influenza vaccine design
09.04.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Injecting gene cocktail into mouse pancreas leads to humanlike tumors
06.04.2018 | University of Texas Health Science Center at San Antonio

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

Im Focus: The Future of Ultrafast Solid-State Physics

In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.

Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...

Im Focus: Stronger evidence for a weaker Atlantic overturning

The Atlantic overturning – one of Earth’s most important heat transport systems, pumping warm water northwards and cold water southwards – is weaker today than any time before in more than 1000 years. Sea surface temperature data analysis provides new evidence that this major ocean circulation has slowed down by roughly 15 percent since the middle of the 20th century, according to a study published in the highly renowned journal Nature by an international team of scientists. Human-made climate change is a prime suspect for these worrying observations.

“We detected a specific pattern of ocean cooling south of Greenland and unusual warming off the US coast – which is highly characteristic for a slowdown of the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Improved stability of plastic light-emitting diodes

19.04.2018 | Power and Electrical Engineering

Enduring cold temperatures alters fat cell epigenetics

19.04.2018 | Life Sciences

New capabilities at NSLS-II set to advance materials science

18.04.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>